MPG.eBooks - Search Results

Cover Image

81

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

82

Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

83

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

84

CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic -- Ipsen Biopharmaceuticals Canada Inc.) : indication: for the symptomatic treatment of...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

85

CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

86

CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

87

CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease

Published 2018

CADTH

Cover Image

88

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

89

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

90

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion Pharmaceuticals Canada Inc.) : Indication: pulmonary arterial hypertension

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

91

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

92

CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

93

CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

94

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

95

CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy

Published 2019

CADTH

Cover Image

96

CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

97

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

98

CADTH Canadian Drug Expert Committee final recommendation: Ticagrelor (Brilinta -- AstraZeneca Canada Inc.) indication : secondary prevention of atherothrombotic events

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

99

CADTH Canadian Drug Expert Committee recommendation: Cerliponase Alfa (Brineura -- Biomarin Pharmaceutical [Canada] Inc.) : indication : for the treatment of neuronal ceroid lipofu...

Published 2019

CADTH

Cover Image

100

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH

1
2
3
4
5
6
7
8
9
10
11